Nurix Therapeutics, Inc. NRIX
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 144.45% | -8.70% | -1.63% | -2.73% | -4.29% |
| Total Receivables | 1,241.18% | -90.82% | 14.29% | 0.00% | 112.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 223.97% | 24.90% | -5.54% | 49.06% | 40.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 150.50% | -11.42% | -1.65% | -2.03% | -3.39% |
|
|
|||||
| Total Current Assets | 150.50% | -11.42% | -1.65% | -2.03% | -3.39% |
| Net Property, Plant & Equipment | -7.46% | 1.63% | 63.70% | 59.07% | 66.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.71% | 23.58% | 28.36% | 104.66% | 112.13% |
| Total Assets | 128.78% | -9.47% | 3.43% | 2.81% | 1.73% |
|
|
|||||
| Total Accounts Payable | 283.13% | 105.04% | 22.58% | -2.33% | 119.73% |
| Total Accrued Expenses | 16.83% | 19.00% | 41.26% | 49.92% | 57.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.51% | -38.47% | -51.77% | -64.76% | -42.15% |
| Total Finance Division Other Current Liabilities | 61.48% | -49.35% | -37.25% | -50.48% | -42.19% |
| Total Other Current Liabilities | 61.48% | -49.35% | -37.25% | -50.48% | -42.19% |
| Total Current Liabilities | 58.76% | -4.75% | 2.46% | -9.79% | -4.57% |
|
|
|||||
| Total Current Liabilities | 58.76% | -4.75% | 2.46% | -9.79% | -4.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.83% | 17.62% | 177.49% | 160.76% | 155.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 125.07% | -72.41% | -68.60% | -61.80% | -49.18% |
| Total Liabilities | 51.10% | -7.67% | 15.74% | 4.94% | 9.85% |
|
|
|||||
| Common Stock & APIC | 23.24% | 23.05% | 23.16% | 21.83% | 22.75% |
| Retained Earnings | 31.88% | -40.71% | -37.14% | -35.80% | -35.99% |
| Treasury Stock & Other | -276.47% | -625.00% | -75.22% | -30.00% | -65.41% |
| Total Common Equity | 160.12% | -10.05% | 0.00% | 2.23% | -1.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 160.12% | -10.05% | 0.00% | 2.23% | -1.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 160.12% | -10.05% | 0.00% | 2.23% | -1.22% |
|
|
|||||